Document is current
Any future updates will be listed below
-
Authors
Suematsu, Yasunori
Morita, Hidetaka
Abe, Makiko
Uehara, Yoshinari
Koyoshi, Rie
Fujimi, Kanta
Ideishi, Akihito
Takata, Kohei
Kato, Yuta
Hirata, Tetsuo
Yahiro, Eiji
Morito, Natsumi
Kitajima, Ken
Yano, Yuiko
Satoh, Atsushi
Yoshimura, Chikara
Ishida, Shintaro
Okutsu, Shota
Takahashi, Koji
Shinohara, Yukiko
Sakaguchi, Takashi
Katsuki, Shiori
Tada, Kazuhiro
Fujii, Takako
Funakoshi, Shunsuke
Hu, Yaopeng
Satoh, Tomonori
Ohnishi, Hirofumi
Okamura, Keisuke
Mizuno, Hiroyuki
Arakawa, Kimika
Asayama, Kei
Ohtsubo, Toshio
Ishigami, Tomoaki
Shibata, Shigeru
Fujita, Takayuki
Munakata, Masanori
Ohishi, Mitsuru
Ichihara, Atsuhiro
Katsuya, Tomohiro
Mukoyama, Masashi
Rakugi, Hiromi
Node, Koichi
Arima, Hisatomi
Miura, Shin-ichiro
- License Information
-
More Information
Article History
Received: 26 August 2024
Revised: 29 September 2024
Accepted: 16 October 2024
First Online: 1 November 2024
Compliance with ethical standards
:
: KO has received grants from Otsuka Holdings. KN has received honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, MSD, Novartis Pharma, Novo Nordisk Pharma, Otsuka; research grants from Astellas, Bayer Yakuhin, Boehringer Ingelheim Japan, Fuji Yakuhin, Mochida Pharmaceutical, Novartis Pharma; and scholarships from Abbott Medical, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Mitsubishi Tanabe Pharma, Teijin Pharma. SM has received honoraria from Daiichi Sankyo, Otsuka Pharma. and Novartis Pharma, scholarships from Abbott Medical and Sumitomo Pharma, and research grants from AMGEN, Bayer Yakuhin, Novo Nordisk Pharma, and MSD.
